Article By: Lillian Mann
Johnson & Johnson has proposed $5.5 billion to settle remaining lawsuits alleging that the pharmaceutical company’s talcum products caused ovarian cancer, contingent on the agreement receiving approval from at least 95% of remaining claimants.
